NIA Small Business Programs’ Post

The case for localization of the manufacture of medical supplies could not be clearer. Take diagnostics. Local manufacture can make tests more available and accessible, improving healthcare for everyone, in particular the most vulnerable. The challenge is bringing in financing to help strengthen existing manufacturers and attract new ones. IFC - International Finance Corporation recognizes the need to increase localization in developing countries and emerging markets. A new report by PATH interviewed 5 local diagnostics manufacturers in Africa about the issue. https://lnkd.in/ey2AcdMK

How intellectual property (IP) can unlock the potential of UK's most promising scale-ups? Aon's new report 'Funding Innovation: Intellectual Property’s Role in Unlocking the Potential of UK Scale-ups' provides an analysis of the funding ecosystem for IP-rich companies in the UK, highlighting the funding gap and the need for innovative financing solutions. It is based on proprietary data from Beauhurst and interviews with investors & leaders from the scale-up ecosystem. With sectors such as pharmaceuticals, medical devices and clinical diagnostics appearing in the top ten sectors for IP-rich businesses, health and life sciences are clearly very important for the UK. “The opportunity is enormous. We don’t have a dearth of ideas in this area – the challenge is in the timelines. Life sciences is a much longer game and more support at the scale-up phase is critically needed. Partnering with big pharma – which has the infrastructure to globalise these technologies – is crucial but we also want to grow globally leading and self-sustaining biotechs here.” said Simon Goldman, Partner AlbionVC.   Request a copy here: https://lnkd.in/e2pFykqJ #ip #intellectualproperty #bigpharma #pharmaceuticals #lifesciences #vc #venturecapital #scaleup #uk #biotech #medicaldevices #clinicaldiagnostics #healthcare

Explore the dynamic growth of healthcare private equity deals in France from 2014 to 2023 with our latest infographic. This analysis focuses on transactions valued over $5 million, covering various sectors, including pharma, medtech, and healthcare providers. The data highlights a steady increase in deal activity from 2014 to 2018, followed by an impressive 17.4% compound annual growth rate from 2019 to 2023. For the interactive graph visit - https://lnkd.in/eMKtDqri #HBI #HealthcareBusinessInternational #PrivateEquity #HealthcareInvestment #HealthcareFrance #Pharma #MedTech #HealthcareProviders #MergersAndAcquisitions #BusinessGrowth #InvestmentTrends #PEDeals

Fascinating insights from Subin Baral on the M&A outlook for FY24 in the Lifesciences sector in the latest EY Firepower Report. Dealmaking looks set to be high on the agenda for businesses in the sector for 2024. Please do feel free to reach out to myself, Caroline Macaskill, Peter Coulthard or Tom Hughes to hear more on what we are seeing in the marketplace as our dedicated Health, Sciences and Wellness Corporate M&A Tax team. Explore more at ey.com/firepower. 🔥🚀 #LifeSciences #BetterWorkingWorld #DealMaking #MNA #Pharma #CorporateMNA 

Take time to study the #guidance coming out of the #EU member state #HTA Coordination Group #HTACG and you may realise how important this #PSI #EFSPI discussion is for the successful #implementation of the #HTAR. Reduction of unnecessary #duplication and raising quality #standards that #EUnetHTA worked for was enabled with the #regulation. Now it's up to the busy HTA doers and the applied scientists to do exactly this in practice! Multidisciplinary topic for #HTAi #ISPOR to foster! https://lnkd.in/dKjB6_qb

🔔 Breaking News in the Healthcare Sector! 🔔 Cinven has launched a public offer for SYNLAB International at €10.00 per share, marking a pivotal moment in the healthcare industry. 📈🚀 This strategic move is sure to have a significant impact on the market and potentially reshape how diagnostic services are delivered across Europe. The fusion of Cinven investment acumen and Synlab’s expertise in diagnostics is poised to unlock new possibilities in healthcare delivery. 💡🤝 🔄 Stay tuned for more updates and explore how this venture will pave the way for innovations and advancements in diagnostic services! #HealthcareInvestment #PublicOffer #Synlab #Cinven #HealthcareInnovation #DiagnosticServices #MarketNews

♨ 🛑 🚨 Flash News ! Europe proposal may accelerate pharma innovation decline, industry group says !! #business #BusinessNews #BreakingNews #BreakingNew #news #financialservices #Finances #trendingnews #NewsUpdates #dailynews #Dailynewspaper #LatestNews #Alert #NewsAlert #europe #world !! Start Today your new Business with FiduLink.com

🔍 Dive into a case study to uncover how Proclinical Group, part of Acacium Group, sourced and implemented candidates to help a MedTech client scale its workforce to meet growth ambitions. 🚀 Read the full case study here >> https://lnkd.in/eaHnRDMy #HealthcareInnovation #ScalingSuccess #PatientOutcomes #AcaciumGroup

The traditional methods of conducting an executive search to find the #best high-ranking #executives have faced a lot of #changes in the last years. That's why we implement top-tier #technological developments with incorporated #AI into our operations, invest in our #online research methods, and #mentoring of our staff. 2024 will be a year of amazing changes 💡 🚀 and even better results for our customers. #executivesearch #emapartnersportugal #besttalent

Congratulations to Alpha IRB on its acquisition by Sabai Global, a portfolio company of Thompson Street Capital Partners, to enhance and expand their Institutional Review Board (IRB) capabilities and geographic footprint. To close our 98th #pharmaservices transaction, Crosstree helped Alpha IRB identify Sabai Global as the ideal partner through: 📈 Presenting the Alpha IRB's unique value proposition to help them achieve the optimal outcome 🤝 Helping Alpha IRB find the right partner to expand their footprint in the US 💲 Positioning to maximize value 📖 Developing and articulating a strong value proposition which connected client capabilities with market trends to weave a compelling narrative for potential buyers Read the full Deal Insights here: https://hubs.li/Q02gRbJ10 #pharma #pharmaceuticalindustry #mergersandacquisitions #investmentbanking #IRB Sabai Global, with Subsidiaries of CBS IBC, Castle IRB, and Shield Consulting Jason Layton